Skip to main content

1 Cash-Producing Stock with Promising Prospects and 2 to Keep Off Your Radar

WH Cover Image

While strong cash flow is a key indicator of stability, it doesn’t always translate to superior returns. Some cash-heavy businesses struggle with inefficient spending, slowing demand, or weak competitive positioning.

Cash flow is valuable, but it’s not everything - StockStory helps you identify the companies that truly put it to work. That said, here is one cash-producing company that reinvests wisely to drive long-term success and two that may face some trouble.

Two Stocks to Sell:

Wyndham (WH)

Trailing 12-Month Free Cash Flow Margin: 15.9%

Established in 1981, Wyndham (NYSE: WH) is a global hotel franchising company with over 9,000 hotels across nearly 95 countries on six continents.

Why Does WH Fall Short?

  1. Revenue per room has underperformed over the past two years, suggesting it may need to develop new facilities
  2. Demand will likely be soft over the next 12 months as Wall Street’s estimates imply tepid growth of 4.2%
  3. Low returns on capital reflect management’s struggle to allocate funds effectively

Wyndham’s stock price of $83.42 implies a valuation ratio of 16.8x forward P/E. Check out our free in-depth research report to learn more about why WH doesn’t pass our bar.

Omnicell (OMCL)

Trailing 12-Month Free Cash Flow Margin: 11%

Driven by the vision of an "Autonomous Pharmacy" with zero medication errors, Omnicell (NASDAQ: OMCL) provides medication management automation and adherence tools that help healthcare systems and pharmacies reduce errors and improve efficiency.

Why Is OMCL Risky?

  1. Products and services are facing significant end-market challenges during this cycle as sales have declined by 5.4% annually over the last two years
  2. Modest revenue base of $1.14 billion gives it less fixed cost leverage and fewer distribution channels than larger companies
  3. Incremental sales over the last five years were much less profitable as its earnings per share fell by 7.6% annually while its revenue grew

At $31.29 per share, Omnicell trades at 16.8x forward P/E. If you’re considering OMCL for your portfolio, see our FREE research report to learn more.

One Stock to Watch:

SPX Technologies (SPXC)

Trailing 12-Month Free Cash Flow Margin: 12.6%

SPX Technologies (NYSE: SPXC) is an industrial conglomerate catering to the energy, manufacturing, automotive, and aerospace sectors.

Why Does SPXC Stand Out?

  1. Market share has increased this cycle as its 13.5% annual revenue growth over the last two years was exceptional
  2. Operating margin improvement of 7.6 percentage points over the last five years demonstrates its ability to scale efficiently
  3. Earnings per share have massively outperformed its peers over the last two years, increasing by 25.5% annually

SPX Technologies is trading at $157.70 per share, or 24.7x forward P/E. Is now the time to initiate a position? Find out in our full research report, it’s free.

Stocks We Like Even More

Donald Trump’s victory in the 2024 U.S. Presidential Election sent major indices to all-time highs, but stocks have retraced as investors debate the health of the economy and the potential impact of tariffs.

While this leaves much uncertainty around 2025, a few companies are poised for long-term gains regardless of the political or macroeconomic climate, like our Top 6 Stocks for this week. This is a curated list of our High Quality stocks that have generated a market-beating return of 183% over the last five years (as of March 31st 2025).

Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,545% between March 2020 and March 2025) as well as under-the-radar businesses like the once-micro-cap company Kadant (+351% five-year return). Find your next big winner with StockStory today for free.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.